TET-101

N/A

Report date: 2024/07/31 13:32:11

Base Information

Drug NameTET-101
Drug Alias NameTET-101
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetraneuron SL
China Registration ClassN/A

Develop Information

Active CompaniesTetraneuron SL
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A